The tech is just too new. i think holders need to wait for a whole new generation of people in decision making seats to get this up. Nice to talk about, but why would the existing drug providers let IMU have a shot. Looks like the game is to ruin any chance of a decent capital raise and then force IMU to use up the cash. 5c looks about the stop to me. The market cap was crazy and even now with nothing in the pipe line its still crazy. Hevag is a duster in my opinion and cf33 looks like its way to revolutionary for the regulators. So sad to see. I think there was a real chance of a deal here a while ago and someone got greedy and blew it.
IMU Price at posting:
9.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)